chiracon provides the pharmaceutical industry with long-standing know-how in the field of drug synthesis. Together with a management system which based on an integrated ISO 9001 system AND includes a GMP environment chiracon can offer all services possible in the field of synthesis drug development for new or generic products. chiracon also offers the compilation of ASMF / DMF and CMC / IMPD documentation.
The foundation of the company took place in 1998. The company is located in Luckenwalde, 40 miles south of Berlin, the capital of Germany. Two airports are close to company: Berlin Tegel (50 min by car) and Berlin – Schönefeld (35 min by car).
Managing Director of chiracon is Dr. Ralf Zuhse. Currently ten scientists for research and development are employed at chiracon. All of them are holding a university or college degree. The scientific staff of the company comes from well-known university research groups, who are leaders of research in the field of modern chiral synthesis. The specialization of these employees in areas such as up-scaling, analytics and quality management provide the basis for our research-oriented activities.
The chiracon GmbH was founded in 1998 with the objective of becoming the partner of choice for the manufacture of quality intermediates and final products for the pharmaceutical sector with innovative manufacturing processes.
chiracon provides the pharmaceutical industry with long-standing know-how in the field of drug synthesis.
Based on modern technologies in the field of chiral chemo- and enzyme catalysis, chiracon offers important technologies, which are crucial for modern drug synthesis. A ISO 9001 management system with an integrated GMP environment, chiracon can offer a fast project management in the field of drug development for new or generic products.
For several years chiracon not only works by the aforementioned management systems, but also the by regulatory aspects.
Each product, whether it is a so-called „New Entity“ or a generic will be already treated within the chiracon even in the first initial stages, that the information („scientific information“) generated will be documented according to the structure of an IMPD or DMF.
The products of the chiracon are marked around the world. Clients range extends from the research departments of large chemical producers, small companies that have insufficient capacity of research through to chemicals trade companies, which reselling our products.